COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF ENZALUTAMIDE FOR THE TREATMENT OF NON- METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN MEXICO

dc.contributor.authorRuiz, B
dc.contributor.authorPolanco, A
dc.contributor.authorSaturnino LMT
dc.contributor.authorFlores Aldana BA
dc.contributor.authorGutierrez M
dc.date.accessioned2024-10-25T19:10:22Z
dc.date.available2024-10-25T19:10:22Z
dc.date.issued2022
dc.identifier.citationRuiz B, Polanco A, Saturnino LTM, Flores Aldana BA, Gutierrez M. COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF ENZALUTAMIDE FOR THE TREATMENT OF NON- METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN MEXICO. VALUE IN HEALTH. 2022. doi: 10.1016/j.jval.2022.09.675
dc.identifier.otherDOI: 10.1016/j.jval.2022.09.675
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/539
dc.language.isoen
dc.publisherVALUE IN HEALTH
dc.titleCOST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF ENZALUTAMIDE FOR THE TREATMENT OF NON- METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN MEXICO
dc.typeArticle
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Ruiz B et al_Value Health.pdf
Tamanho:
654.5 KB
Formato:
Adobe Portable Document Format
Descrição:
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição: